E-santé et big data : l'appli Sweetch (Israël), veut empêcher le diabète de se déclarer et lève 3,5M$
[:fr]
Sweetch vient de lever 3,5 M$ pour développer sa technologie visant à identifier les individus qui risquent de développer le diabète ou d’autres maladies chroniques. Le tour de table a réuni le groupe Philips et la plate-forme de crowdfunding OurCrowd basée à Jérusalem, avec la participation des investisseurs Pontifax et Lionbird. «Nous sommes fiers d’avoir la confiance de ces entreprises mondiales reconnues. Nous avons une mission à réaliser, faire en sorte que la population mondiale soit en meilleure santé, et cela ne peut se faire que grâce à l’utilisation d’appareils intelligents connectés avec l’analyse du big data et au niveau individuel », explique Dana Chanan, CEO et co-fondatrice de Sweetch.
Avec 387 millions de patients diabétiques dans le monde, le diabète est la principale cause des maladies chroniques les plus importantes telles que la crise cardiaque, les accidents vasculaires cérébraux, l’insuffisance cardiaque congestive, l’insuffisance rénale, la cécité et les amputations. Selon l’American Diabetes Association, on estime que 600 milliards $ par an sont dépensés pour le diabète aux Etats-Unis seuls.
Plusieurs grandes études cliniques ont prouvé que 150 minutes d’activité par semaine réduisent le risque de conversion prédiabète-diabète de 58%. Les mêmes études indiquent que 80% des pré-diabétiques ne respectent pas les recommandations de l’OMS, des Centers for Disease Control and Prevention, et de l’American Heart Association. Dana Chanan conclue : « pour beaucoup de gens, la notion de 150 minutes d’exercice peut être rebutante, aussi Sweetch introduit un mode de vie sain par petites étapes ».
[:en]Sweetch, an Israeli digital health startup, is on a mission to make the world a healthier place. Its first undertaking: to prevent people who are at risk for diabetes from developing the disease. More than 86 million US and 63 million European adults have a blood-sugar level that is higher than normal but not yet high enough to be considered diabetes, according to statistics. This pre-diabetic population will most likely develop Type 2 diabetes without intervention.
And that’s why health professionals and venture capitalists are celebrating Sweetch’s recent Series A financing round of $3.5 million to advance its technology designed to identify and coach individuals at risk of developing diabetes and other chronic conditions. The round was led by Philips and the Jerusalem-based OurCrowd equity crowdfunding platform, with participation from prior investors Pontifax and Lionbird.
“We are very proud to be trusted by such global and well-known companies. We have a mission to achieve – make the world a healthier place on a large scale, and this can be done only through the use of smart devices connected with big-data analytics and the individual level,” says Dana Chanan, Sweetch CEO and cofounder. Sweetch, founded in 2013, has developed a clinical-outcome prediction platform and a behavioral analytics engine.
The machine-learning platform assists in identifying individuals at risk of developing diabetes as a tool for early intervention and resource allocation by healthcare providers. Chanan says figures show that current methods for identifying pre-diabetics miss about 92.5 percent of the actual future diabetic population. The behavioral analytics engine and mobile application serve as a personal digital health coach to help people learn how to modify their habits. Sweetch takes its name from “sweet” – a reference to diabetes – and “switch,” in reference to switching one’s lifestyle.
Gaming in the digital health arena
The new funding will be used to complete a pilot program and clinical trials at an internationally renowned US medical institution, which Chanan says she cannot name. Eventually, physicians will be able to prescribe the Sweetch app – currently only available to clinical trial participants — for pre-diabetic and other health conditions. “If the doctor sees you’re in the high-risk group, he or she will be able to give you a prescription for Sweetch. You’ll go to the app, enter the code, and start using the app,” she says. Although reports show that people often stop using wearable health-tracking devices within six months, Chanan says this is because an engagement component is missing. As a former executive team member at Playtech, 888 and Snaptu, she has brought her gaming experience to the digital health arena.
“Diabetes is definitely not a game,” she tells ISRAEL21c, “but one of the successes of the gaming industry is its capability to analyze and provide a specific experience for the user as if he’s the only user that exists.” Sweetch’s proprietary behavioral analytics engine continuously learns the user’s daily habits and uses gamification and behavioral-science methodologies to translate that data into personalized recommendations. These conclusions are then adapted, in real-time, to the user’s actual performance. “There is no fixed goal that everyone has to achieve. Not everyone is the same. The recommendations and program are for a specific user,” says Chanan.
150 minutes of health
There are 387 million diabetic patients globally, and diabetes is the leading cause of the most significant chronic diseases such as heart attack, stroke, congestive heart failure, renal failure, blindness and amputations. According to the American Diabetes Association, an estimated $600 billion a year is spent on diabetes in the US alone. Several large clinical studies have proven that 150 minutes of activity per week reduce the prediabetes-to-diabetes conversion risk by 58%. The same reports show that 80% of pre-diabetics do not adhere to recommendations from organizations such as the World Health Organization, Centers for Disease Control and Prevention, and American Heart Association. Chanan says that for many people, the notion of 150 minutes of exercise can be off-putting. So Sweetch introduces healthier lifestyle in small steps.
Source israel21c[:]
